« Arbour Group Observes Increased 21 CFR Part 11 Compliance ActivityCHICAGO, | Main | FDA approves system to repair abdominal aneurysms in people with »

FDA Statement on Makena FDA approved Makena (hydroxyprogesterone caproate) in


FDA Statement on Makena
FDA approved Makena (hydroxyprogesterone caproate) in February 2011 for the reduction of the risk of certain preterm births in women who have had at least one prior preterm birth.
 

©2006 FDA-News.com. All rights reserved.